Pharma Logistics IQ sat down with Paul O'Connor, Global Vice President Quality, Almac who are a sponsor of the Clinical Trial Supply Forum, to talk about the potential effects of Brexit on the industry and how ALMAC is preparing for these changes.
Pharma IQ sat down with Buz Hillman, Associate Director, Clinical Supply Systems and Strategy, Janssen and Steven Jacobs Board Chairman, Global Clinical Supplies Group ahead of the Clinical Trial Supply Forum. They discussed in detail topics such as utilising data to drive supply-chain efficiencies and generate the process insights.
With 253,834 studies located in 200 countries, ensuring smooth and cost-effective global clinical trial supply has become a standard for the pharmaceutical industry. Experts from all regions have answered our survey on the main pain points they face, how they can improve their supply chain and what drives its success. Anat Batsri, Global Clinical Supply Chain Study Lead at OPKO Biologics, had a look at the results and gave us her feedback on what the results showed.
Improving clinical trial supply through innovative supply chain platforms: Challenges and opportunities
Clinical trials are on the rise and new designs such as adaptive clinical trials are emerging, requiring flexibility and transparency and forcing pharma companies to re-assess their approach to their supply chain to adapt to these changes. Ahead of the Clinical Trial Supply Forum, we sat down with one of the speakers, Antony Pham, Co-founder of consulting and tech-based SPLY ApS to discuss the opportunities and challenges associated with the implementation of new technologies in the supply chain and how they can increase the companies' efficiency while reducing costs.